细胞毒性T细胞
CXCL10型
癌症研究
下调和上调
免疫系统
头颈部鳞状细胞癌
T细胞
生物
趋化因子
效应器
细胞生物学
细胞
信号转导
趋化因子受体
旁分泌信号
免疫学
CCR10
细胞因子
肿瘤微环境
CCL5
免疫
癌细胞
受体
医学
细胞信号
先天免疫系统
癌症免疫疗法
癌变
免疫疗法
电池类型
作者
Frederico O. Gleber‐Netto,Deborah A. Silverman,Tongxin Xie,Shamima Akhter,Nicole Vaughn,Adewale Adebayo,Kala Chand Debnath,Shorook Naara,Shajedul Islam,Erik Knutsen,Emily Lorin Ashkin,Simone Anfossi,Sara Elizabeth Leahey,Patrick Hwu,Sébastien Talbot,Erica K. Sloan,Robert Saddawi‐Konefka,Roberto Rangel,Jeffrey N. Myers,George A. Calin
标识
DOI:10.1002/advs.202516859
摘要
ABSTRACT Head and neck squamous cell carcinoma (HNSCC) is notoriously resistant to immunotherapy. The interplay between β‐adrenergic signaling and p53 loss, both key regulators of immune responses, has remained largely unexplored in the setting of tumor‐immune evasion. This study demonstrates that pharmacologic stimulation of β2‐adrenergic receptors with isoprenaline significantly enhances cytotoxic T cell activity against p53‐deficient HNSCC cells via a CXCL10‐dependent paracrine mechanism. Comprehensive transcriptomic and co‐culture assays reveal that p53‐null cancer cells upregulate CXCL10, which promotes CD8 + T cell recruitment and activation. Neutralization of CXCL10 abolishes the β‐adrenergic‐induced cytotoxic T cell response, establishing this chemokine as a pivotal mediator. Using tyrosine hydroxylase knockout mouse models, we show that adrenergic innervation is essential for intra‐tumoral CXCL10 expression and the infiltration of effector CXCR3 + T cells in vivo. Notably, the CXCL10‐driven T cell response is associated with simultaneous upregulation of both activation and exhaustion markers, indicating a robust but transient effector state within the tumor microenvironment. Collectively, these findings uncover a neuro‐immune axis that reverses immune escape in p53‐deficient HNSCC and suggest novel therapeutic strategies targeting adrenergic signaling to convert immune “cold” tumors into “hot” ones more amenable to immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI